Kathleen T. Brady, MD, PhD

Department of Psychiatry and Behavioral Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina

  • 12Articles
  • 48.5KReads
  • 1997–2025Active
  • 61Collaborators
  • 191Citations

About

Kathleen T. Brady, MD, PhD, is affiliated with the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina. Her publications from 1997 to 2025 focus on posttraumatic stress disorder, addiction, bipolar disorder, depression, and issues affecting veterans and military populations. She has contributed to clinical trials and reviews addressing treatments such as N-acetylcysteine, doxazosin, risperidone, and gabapentin, as well as the comorbidity of psychiatric disorders with PTSD. Her work often explores the complexities of diagnosis and management in these areas.

Publications

JCP
N-acetylcysteine for Co-occurring PTSD and Alcohol Use Disorder: A Double-Blind, Randomized Controlled Trial
Original Research

N-acetylcysteine for Co-occurring PTSD and Alcohol Use Disorder: A Double-Blind, Randomized Controlled Trial

August 27, 2025

Among individuals with PTSD and alcohol use disorder receiving CBT and either NAC or placebo, both groups had significant reductions in both PTSD symptom severity and alcohol use, with...
, , , et al
JCP
Doxazosin for the Treatment of PTSD and AUD
Original Research

Doxazosin for the Treatment of PTSD and AUD

March 8, 2023

This study is the first to evaluate doxazosin, an α1-adrenergic antagonist, in veterans with both PTSD and alcohol use disorder.
, , , et al
JCP
Original Research

NAC for PTSD and SUD

November 23, 2016

Knowing that patients with posttraumatic stress disorder and substance use disorder share impaired prefrontal cortex regulation, particularly at glutamate synapses in the nucleus accumbens, the authors conducted this first-ever...
, , , et al
JCP
Original Research

Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials

July 31, 2008

, , , et al
JCP
Original Research

Placebo-Controlled Trial of Risperidone Augmentation for Selective Serotonin Reuptake Inhibitor-Resistant Civilian Posttraumatic Stress Disorder

March 18, 2008

, , , et al
JCP
Academic Highlights

Advances in the Treatment of Alcohol Dependence.

July 16, 2007

, , , et al
JCP
Article

Overview of Psychiatric Disorders and the Role of Newer Antidepressants

January 1, 2002

, , , et al
JCP
Original Research

Gabapentin in the Treatment of Cocaine Dependence: A Case Series

January 1, 2001

, , , et al
JCP
Article

Difficulties in Diagnosis and Management of Bipolar Disorder: Three Case Presentations

November 30, 2000

PCC
Article

Comorbidity of Psychiatric Disorders and Posttraumatic Stress Disorder

April 30, 2000

, , , et al
JCP
Article

Comorbidity of Psychiatric Disorders and Posttraumatic Stress Disorder

April 30, 2000

, , , et al
JCP
Article

Posttraumatic Stress Disorder and Comorbidity: Recognizing the Many Faces of PTSD

March 1, 1997

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe